Inventor · disambiguated record
Samuel Aparicio
Also filed as: APARICIO SAMUEL · APARICIO SAMUEL ALVES JANA RODRIGUES
3 granted patents·15 pending applications·15 citations·filing 2003–2024
63Inventor score
Files withUNIV BRITISH COLUMBIA6TAKEDA PHARMACEUTICAL3CANEXIA HEALTH INC2APARICIO SAMUEL1PACBRIDGE PARTNERS II INVEST CO LTD1
Top patents by PatentIndex Score
18 records- 0190US10760121B2Methods for analyzing genomic variation within cellsUNIV BRITISH COLUMBIA·Filed 2016·Granted Sep 1, 2020·14 cites·18 claims
- 0280US11434530B2Methods for analyzing genomic variation within cellsUNIV BRITISH COLUMBIA·Filed 2020·Granted Sep 6, 2022·1 cites·24 claims
- 0372US2023091562A1Methods and Devices for Analyzing ParticlesUNIV BRITISH COLUMBIA·Filed 2022·Application pending·0 cites
- 0471US2023348999A1Stratification and prognosis of cancerUNIV BRITISH COLUMBIA·Filed 2023·Application pending·0 cites
- 0570US2022275463A1Stratification and prognosis of cancerUNIV BRITISH COLUMBIA·Filed 2022·Application pending·0 cites
- 0664US2024409990A1Molecular quality assurance methods for use in sequencingPACBRIDGE PARTNERS II INVEST CO LTD·Filed 2024·Application pending·0 cites
- 0757US2020308650A1Stratification and prognosis of cancerUNIV BRITISH COLUMBIA·Filed 2018·Application pending·0 cites
- 0854US2010272647A1ReceptorTAKEDA PHARMACEUTICAL·Filed 2009·Application pending·0 cites
- 0950US2005160486A1ReceptorFiled 2004·Application pending·0 cites
- 1049US2021155980A1Molecular quality assurance methods for use in sequencingCANEXIA HEALTH INC·Filed 2021·Application pending·0 cites
- 1145US2010158807A1ReceptorTAKEDA PHARMACEUTICAL·Filed 2009·Application pending·0 cites
- 1244US10934580B2Molecular quality assurance methods for use in sequencingCANEXIA HEALTH INC·Filed 2016·Granted Mar 2, 2021·0 cites·9 claims
- 1343US2005064549A1ReceptorFiled 2004·Application pending·0 cites
- 1442US2008269118A1Use of Gpr100 receptor in diabetes and obesity regulationAPARICIO SAMUEL·Filed 2006·Application pending·0 cites
- 1542US2005026825A1ReceptorFiled 2003·Application pending·0 cites
- 1635US2010311077A1Use of GPR100 Receptor in Diabetes and Obesity RegulationTAKEDA PHARMACEUTICAL·Filed 2010·Application pending·0 cites
- 1733US2004025199A1ReceptorFiled 2003·Application pending·0 cites
- 1825US2006015954A1GPR54 knock-out mammals and screening methods using themPARADIGM THERAPEUTICS LTD·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Samuel Aparicio files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →